The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Sarmad Sadeghi
Employment - BeiGene (I)
Consulting or Advisory Role - Cardinal Health
Research Funding - Merck; Pfizer; VasGene Therapeutics, Inc
 
Samuel Callis
No Relationships to Disclose
 
Primo Lara
Research Funding - AstraZeneca (Inst)
 
Stephanie Berg
Honoraria - Aptitude Health; Curio Science
Consulting or Advisory Role - Eisai; Exelixis; Guardant Health; Natera; Pfizer; Zencor
Travel, Accommodations, Expenses - Exelixis
 
Jason Brown
Honoraria - Ipsen; Johnson & Johnson/Janssen
Consulting or Advisory Role - AstraZeneca; EMD Serono; Johnson & Johnson/Janssen; Pfizer
Speakers' Bureau - Merck
Research Funding - Bicycle Therapeutics (Inst); Indaptus Therapeutics; Merck (Inst); Novita Pharmaceuticals (Inst); Pfizer (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Johnson & Johnson/Janssen
 
Adanma Ayanambakkam
Consulting or Advisory Role - AVEO; Johnson and Johnson; Kura Oncology; Pfizer/Astellas
Research Funding - Regeneron
Travel, Accommodations, Expenses - Kura Oncology
 
Suzanne Cole
Research Funding - Merck (Inst)
 
Elizabeth Kessler
Honoraria - Astellas Scientific and Medical Affairs Inc
Research Funding - Bristol-Myers Squibb (Inst); Johnson & Johnson/Janssen (Inst); Lilly (Inst); Merck Serono (Inst); Pfizer (Inst)
 
Daniel Vaena
Honoraria - HMP; Medical Education Consortium; OncLive; Total Health Conferencing
Consulting or Advisory Role - Aptitude Health; Astellas Pharma; AstraZeneca; Avyxa; Bayer; Cardinal Health; Clinical Education Alliance; Curio/Vaniam Group; DAVA Pharmaceuticals; EMD Serono; Exelixis; Gilead Sciences; IDEOlogy Health; IntrinsiQ; Janssen; MJH Life Sciences; Revolution Medicines; Sanofi; Seagen
Research Funding - ALX Oncology (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Compugen (Inst); Eikon (Inst); Exelixis (Inst); Merck (Inst); OBI Pharma (Inst); Roche/Genentech (Inst); Seagen (Inst); Tallac Therapeutics (Inst); Tizona Therapeutics, Inc. (Inst)
 
Greg Angstreich
No Relationships to Disclose
 
Theodore Gourdin
Consulting or Advisory Role - Pfizer; Sanofi
Research Funding - Ferring (Inst)
 
Nataliya Mar
Consulting or Advisory Role - Astellas Pharma; AVEO; EMD Serono; Exelixis; Johnson and Johnson; Pfizer
Speakers' Bureau - Eisai; Merck
Research Funding - Gilead Sciences
 
Rick Bangs
Honoraria - Astellas Pharma; AstraZeneca; Gilead Sciences; Pfizer
Consulting or Advisory Role - CVS Health; Gilead Sciences; Janssen Oncology; Nonagen Bioscience
Travel, Accommodations, Expenses - Astellas Pharma; AstraZeneca; Gilead Sciences; Janssen Oncology; Pfizer
Other Relationship - Bladder Cancer Advocacy Network; National Cancer Institute; SWOG; SWOG; SWOG
(OPTIONAL) Uncompensated Relationships - Genentech; Gilead Sciences
 
Darrell Nakagawa
Leadership - Bladder Cancer Advocacy Network
Honoraria - Tyra Biosciences
 
Siamak Daneshmand
Stock and Other Ownership Interests - Taris
Honoraria - Allergan (I); AstraZeneca; Bausch and Lomb (I); Bristol-Myers Squibb; CG Oncology; enGene; Ferring; ImmunityBio; Johnson & Johnson; Lilly; pacific edge; Pfizer; Photocure; Protara Therapeutics; Storz; Urogen pharma
Consulting or Advisory Role - AstraZeneca; AstraZeneca; Bristol-Myers Squibb/Pfizer; CG Oncology; enGene; Ferring; ImmunityBio; Johnson & Johnson/Janssen; pacific edge; Pfizer; Photocure; Taris; Urogen pharma; UroToday
Research Funding - Photocure
Travel, Accommodations, Expenses - Janssen Oncology; Photocure
 
Ian Thompson
Employment - CHRISTUS Health
Leadership - H-E-B (grocery store chain)
Consulting or Advisory Role - Magforce
Research Funding - MagForce
Patents, Royalties, Other Intellectual Property - I have several patents with colleagues involving novel biomarkers for cancer and two devices for sexual dysfunction and urinary incontinence. No revenues at this time and our University IP office is working with industry to determine if these can be comme
 
Thomas Flaig
Leadership - Aurora Oncology; CPC - Clinical Research and Community Health; University of Colorado/UC Health
Stock and Other Ownership Interests - Aurora Oncology
Research Funding - Agensys; Aragon Pharmaceuticals; Astellas Pharma; astrazeneca/MedImmune; Bavarian Nordic; Bristol-Myers Squibb; Criterium; Dendreon; Exelixis; GTx; Janssen Oncology; La Roche-Posay; Lilly; Medivation; Merck; Myovant Sciences; Novartis; Pfizer; Roche/Genentech; Sanofi; Seagen; Seagen; Sotio; Tokai Pharmaceuticals
Patents, Royalties, Other Intellectual Property - The University of Colorado has filed 2 patents in which I am an inventor. These are related to early-stage bladder cancer treatment and detection. Neither is commercialized or in active clinical development right now (e.g. neither are in clinical trials).
 
Daniel Petrylak
Consulting or Advisory Role - Advanced Accelerator Applications; Amgen; Astellas Pharma; AstraZeneca; Bayer; Bicycle Therapeutics; Boehringer Ingelheim; Bristol-Myers Squibb; Clovis Oncology; Exelixis; Gilead Sciences; Incyte; Ipsen; Janssen; Lilly; Mirati Therapeutics; Monopteros Therapeutics; Pfizer; Pharmacyclics; Regeneron; Roche; Seagen; Urogen pharma
Research Funding - Advanced Accelerator Applications (Inst); Agensys (Inst); Astellas Medivation (Inst); AstraZeneca (Inst); Bayer (Inst); BioXCel therapeutics (Inst); Bristol-Myers Squibb (Inst); Clovis Oncology (Inst); Eisai (Inst); Endocyte (Inst); Genentech (Inst); Gilead Sciences (Inst); Innocrin Pharma (Inst); Lilly (Inst); MedImmune (Inst); Medivation (Inst); Merck (Inst); Mirati Therapeutics (Inst); Novartis (Inst); Pfizer (Inst); Progenics (Inst); Replimune (Inst); Roche (Inst); Sanofi (Inst); Seagen (Inst)
Expert Testimony - Celgene; sanofi
 
Seth Lerner
Stock and Other Ownership Interests - Aura Biosciences; C2i genomics
Honoraria - Grand Rounds in Urology; UroToday
Consulting or Advisory Role - AstraZeneca; Aura Biosciences; Bristol-Myers Squibb Foundation/Janssen; Ferring; Gilead Sciences; ImmunityBio; Protara Therapeutics; SURGE Therapeutics; Trigone Pharma; Urogen pharma; Vaxiion; Verity Pharmaceuticals
Research Funding - Aura Biosciences; FKD Therapies; Japan BCG Laboratory; QED Therapeutics; Roche/Genentech; SURGE Therapeutics; Vaxiion
Patents, Royalties, Other Intellectual Property - TCGA expression subtype singel patient classifier
Other Relationship - Bladder Cancer Journal; UpToDate